"The Future of Marijuana Rescheduling Will Ultimately Be Decided by Federal Judges, Not Administrative Witnesses" says Duane ...
Opinion: The rescheduling of medical marijuana could be the start of a broader rescheduling initiative that would affect ...
Three Republican attorneys general are asking a federal appeals court to block the Trump administration's push to reschedule ...
Earlier this week, news leaked of the biggest change in federal drug policy in more than half a century. The Associated Press reported—and the Department of Justice later confirmed—that the Drug ...
The cannabis industry won't have a direct voice in potentially historic hearings next week. And a final outcome is far from certain.
The rescheduling of medical cannabis to Schedule III has paradoxically created significant uncertainty for banks serving the ...
A DEA hearing to consider marijuana rescheduling will hear evidence and testimony only from cannabis reform's enemies, the agency said.
The move only shifted a certain category of weed.
Tilray Brands is back in focus as analysts reset their thinking on where the stock might be headed, with some firms cutting price targets in both US$ and C$ while others keep their fair value view ...
The proposed rescheduling of cannabis currently under consideration by the Department of Health and Human Services, the Department of Justice and the Drug Enforcement Agency would move it from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results